Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase

Cancer Research

Volumn 63, Issue 13, 2003, Pages 3654-3658

  Weiss, Michael ^a   Hettmer, Simone ^a   Smith, Paul ^b   Ladisch, Stephan ^a,c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b Oxford GlycoSciences   (United Kingdom)

^c CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR; GANGLIOSIDE; GLUCOSYLCERAMIDE; GLYCOSPHINGOLIPID; OGT 2378; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; LIPOGENESIS; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; ENZYME INHIBITORS; GANGLIOSIDES; GLUCOSYLTRANSFERASES; IMINO SUGARS; MELANOMA, EXPERIMENTAL; MICE; PIPERIDINES; TUMOR CELLS, CULTURED;

EID: 0038079762     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hakomori, S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res., 56: 5309-5318, 1996.
2. Ladisch, S., Gillard, B., Wong, C., and Ulsh, L. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer Res., 43: 3808-3813, 1983.
3. Ladisch, S., and Wu, Z. L. Detection of a tumour-associated ganglioside in plasma of patients with neuroblastoma. Lancet, 1: 136-138, 1985.
4. Bernhard, H., Meyer zum Buschenfelde, K. H., and Dippold, W. G. Ganglioside GD3 shedding by human malignant melanoma cells. Int. J. Cancer, 44: 155-160, 1989.
5. Merritt, W. D., Der-Minassian, V., and Reaman, G. H. Increased GD3 ganglioside in plasma of children with T-cell acute lymphoblastic leukemia. Leukemia (Baltimore), 8: 816-822, 1994.
6. Olshefski, R., and Ladisch, S. Intercellular transfer of shed tumor cell gangliosides. FEBS Lett., 386: 11-14, 1996.
7. Lu, P., and Sharom, F. J. Immunosuppression by YAC-lymphoma: role of shed gangliosides. Cell. Immunol., 173: 22-32, 1996.
8. Bergelson, L. D., Dyatlovitskaya, E. V., Klyuchareva, T. E., Kryukova, E. V., Lemenovskaya, A. F., Matveeva, V. A., and Sinitsyna, E. V. The role of glycosphingolipids in natural immunity. Gangliosides modulate the cytotoxicity of natural killer cells. Eur. J. Immunol., 19: 1979-1983, 1989.
9. Grayson, G., and Ladisch, S. Immunosuppression by human gangliosides. II. Carbohydrate structure and inhibition of human NK activity. Cell. Immunol., 139: 18-29, 1992.
10. Alessandri, G., Filippeschi, S., Sinibaldi, P., Mornet, F., Passera, P., Spreafico, F., Cappa, P. M., and Gullino, P. M. Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells. Cancer Res., 47: 4243-4247, 1987.
11. Manfredi, M. G., Lim, S., Claffey, K. P., and Seyfried, T. N. Gangliosides influence angiogenesis in an experimental mouse brain tumor. Cancer Res., 59: 5392-5397, 1999.
12. Zeng, G., Gao, L., Birkle, S., and Yu, R. K. Suppression of ganglioside GD3 expression in a rat F-tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Cancer Res., 60: 6670-6676, 2000.
13. Lang, Z., Guerrera, M., Li, R., and Ladisch, S. Ganglioside GD1a enhances VEGF-induced endothelial cell proliferation and migration. Biochem. Biophys. Res. Commun., 282: 1031-1037, 2001.
14. Li, R., Liu, Y., and Ladisch, S. Enhancement of epidermal growth factor signaling and activation of SRC kinase by gangliosides. J. Biol. Chem., 276: 42782-42792, 2001.
15. Rusnati, M., Urbinati, C., Tanghetti, E., Dell'Era, P., Lortat-Jacob, H., and Presta, M. Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2. Proc. Natl. Acad. Sci. USA, 99: 4367-4372, 2002.
16. Ladisch, S., Hasegawa, A., Li, R., and Kiso, M. Immunosuppressive activity of chemically synthesized gangliosides. Biochemistry, 34: 1197-1202, 1995.
17. Valentino, L., Moss, T., Olson, E., Wang, H. J., Elashoff, R., and Ladisch, S. Shed tumor gangliosides and progression of human neuroblastoma. Blood, 75: 1564-1567, 1990.
18. Ladisch, S., Kitada, S., and Hays, E. F. Gangliosides shed by tumor cells enhance tumor formation in mice. J. Clin. Investig., 79: 1879-1882, 1987.
19. Deng, W., Li, R., and Ladisch, S. Influence of cellular ganglioside depletion on tumor formation. J. Natl. Cancer Inst. (Bethesda), 92: 912-917, 2000.
20. Ranes, M. K., El-Abbadi, M., Manfredi, M. G., Mukherjee, P., Platt, F. M., and Seyfried, T. N. N-butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. Br. J. Cancer, 84: 1107-1114, 2001.
21. Deng, W., Li, R., Guerrera, M., Liu, Y., and Ladisch, S. Transfection of glucosylceramide synthase antisense inhibits mouse melanoma formation. Glycobiology, 12: 145-152, 2002.
22. Cox, T., Lachmann, R., Hollak, C., Aerts, J., van Weely, S., Hrebicek, M., Platt, F., Butters, T., Dwek, R., Moyses, C., Gow, I., Elstein, D., and Zimran, A. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet, 355: 1481-1485, 2000.
23. Platt, F. M., Neises, G. R., Dwek, R. A., and Butters, T. D. N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J. Biol. Chem., 269: 8362-8365, 1994.
24. Platt, F. M., Reinkensmeier, G., Dwek, R. A., and Butters, T. D. Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycin. J. Biol. Chem., 272: 19365-19372, 1997.
25. Ichikawa, S., Nakajo, N., Sakiyama, H., and Hirabayashi, Y. A mouse B16 melanoma mutant deficient in glycolipids. Proc. Natl. Acad. Sci. USA, 91: 2703-2707, 1994.
26. Olshefski, R. S., and Ladisch, S. Glucosylceramide synthase inhibition enhances vincristine-induced cytotoxicity. Int. J. Cancer, 93: 131-138, 2001.
27. Ladisch, S., and Gillard, B. A solvent partition method for microscale ganglioside purification. Anal. Biochem., 146: 220-231, 1985.
28. Fewster, M. E., Burns, B. J., and Mead, J. F. Quantitative densitometric thin-layer chromatography of lipids using copper acetate reagent. J. Chromatogr., 43: 120-126, 1969.
29. Liu, Y. Y., Han, T. Y., Giuliano, A. E., Hansen, N., and Cabot, M. C. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J. Biol. Chem., 275: 7138-7143, 2000.
30. Markwell, M. A., Haas, S. M., Tolbert, N. E., and Bieber, L. L. Protein determination in membrane and lipoprotein samples: manual and automated procedures. Methods Enzymol., 72: 296-303, 1981.
31. Ledeen, R. W., and Yu, R. K. Gangliosides: structure, isolation, and analysis. Methods Enzymol., 83: 139-191, 1982.
32. Schutte, B., Tinnemans, M. M., Pijpers, G. F., Lenders, M. H., and Ramaekers, F. C. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content. Cytometry, 21: 177-186, 1995.
33. Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J. Immunol. Methods, 184: 39-51, 1995.
34. Radin, N. S., Shayman, J. A., and Inokuchi, J. Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. Adv. Lipid Res., 26: 183-213, 1993.
35. Li, R., Manela, J., Kong, Y., and Ladisch, S. Cellular gangliosides promote growth factor-induced proliferation of fibroblasts. J. Biol. Chem., 275: 34213-34223, 2000.
36. Inokuchi, J., Jimbo, M., Momosaki, K., Shimeno, H., Nagamatsu, A., and Radin, N. S. Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action. Cancer Res., 50: 6731-6737, 1990.
37. Manning, L. S., and Radin, N. S. Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cells. Br. J. Cancer, 81: 952-958, 1999.
38. Jeyakumar, M., Butters, T. D., Cortina-Borja, M., Hunnam, V., Proia, R. L., Perry, V. H., Dwek, R. A., and Platt, F. M. Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Proc. Natl. Acad. Sci. USA, 96: 6388-6393, 1999.